| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 2138-98-9 | 2-氨基-5-(2-氯苯基)-1,3,4-恶二唑 | 2-Amino-5-(2-chlorophenyl)-1,3,4-oxadiazole; 5-(2-Chlorophenyl)-1,3,4-oxadiazol-2-amine | ![]() | C8H6ClN3O | 详情 | 供应商 |
| 16142-27-1 | 5-氨基-3-(4-吗啉基)-1,2,3-恶二唑鎓盐酸盐 | 3-Morpholinosydnonimine hydrochloride; SIN-1 hydrochloride; 5-Amino-3-morpholinyl-1,2,3-oxadiazolium chloride | ![]() | C6H11N4O2.Cl | 详情 | 供应商 |
| 17220-38-1 | 3,4-二氨基呋扎; 3,4-二氨基-1,2,5-恶二唑 | 3,4-Diaminofurazan; 3,4-Diamino-1,2,5-oxadiazole; Furazandiamine | ![]() | C2H4N4O | 详情 | 供应商 |
| 78350-50-2 | 3-氨基呋咱-4-羧酸; 4-氨基-1,2,5-恶二唑-3-羧酸 | 3-Aminofurazan-4-carboxylic acid; 4-Aminofurazan-3-carboxylic acid; 5-Aminofurazane-4-carboxylic acid; 4-Amino-1,2,5-oxadiazole-3-carboxylic acid | ![]() | C3H3N3O3 | 详情 | 供应商 |
| 153216-47-8 | 3-(1-甲基-2-苯基乙基)-5-[[(苯基氨基)甲酰]氨基]-1,2,3-恶二唑L-谷氨酸 | Sydnogluton; Sydnocarb glutamic acid; 3-(1-Methyl-2-phenylethyl)-5-[[(phenylamino)carbonyl]amino]-1,2,3-oxadiazole L-glutamic acid | ![]() | C23H29N5O6 | 详情 | 供应商 |
| 7659-06-5 | 5-呋喃-2-1,3,4 -恶二唑-2-氨基; 5-呋喃-2-1,3,4 -恶二唑-2-氨基 | 1,3,4-Oxadiazol-2-amine,5-(2-furanyl)-; 1,3,4-Oxadiazole,2-amino-5-(2-furyl)- (6CI,7CI,8CI); 2-Amino-5-(2-furyl)-1,3,4-oxadiazole | ![]() | C6H5N3O2 | 详情 | 供应商 |
| 52838-39-8 | 2-氨基-5-甲基-1,3,4-恶二唑; 5-甲基-1,3,4-恶二唑-2-胺 | 1,3,4-Oxadiazol-2-amine,5-methyl-; 1,3,4-Oxadiazole,2-amino-5-methyl- (6CI); (5-Methyl-1,3,4-oxadiazol-2-yl)amine; 2-Amino-5-methyl-1,3,4-oxadiazole; 5-Methyl-1,3,4-oxadiazol-2-amine | ![]() | C3H5N3O | 详情 | 供应商 |
| 664985-43-7 | DAABD-CL[=4-(二甲氨基)乙氨基磺酰]-7-氯-2,1,3-苯并恶二唑][用于蛋白质组分析] | 4-[2-(DIMETHYLAMINO)ETHYLAMINOSULFONYL]-7-CHLORO-2,1,3-BENZOXADIAZOLE; DAABD-CL; 4-[2-(DIMETHYLAMINO)ETHYLAMINOSULFONYL]-7-CHLORO-2,1,3-BENZOXADIAZOLE; DAABD-Cl [=4-[2-(Dimethylamino)ethylaminosulfonyl]-7-chloro-2,1,3-benzoxadiazole] [for Proteome Analysis]; DAABD-Cl [=4-[2-(Dimethylamino)ethylaminosulfonyl]-7-chloro-2,1,3-benzoxadiazole] | ![]() | C10H13ClN4O3S | 详情 | 供应商 |
| 163927-31-9 | (R)-(-)-4-(N,N-二甲氨基磺酰)-7-(3-异硫氰酸基吡咯烷-1-基)-2,1,3-苯并恶二唑[用于高效液相色谱标记] | (R)-(-)-DBD-PY-NCS; (R)-(-)-DBD-PY-NCS; (R)-DBD-PY-NCS; (R)-(-)-4-(N,N-DIMETHYLAMINOSULFONYL)-7-(3-ISOTHIOCYANATOPYRROLIDIN-1-YL)-2,1,3-BENZOXADIAZOLE; (R)-(-)-4-(N,N-DIMETHYLAMINOSULFONYL)-7-(3-ISOTHIOCYANATOPYRROLIDIN-1-YL)BENZOFURAZAN; (R)-4-(N,N-DIMETHYLAMINOSULFONYL)-7-(3-ISOTHIOCYANATOPYRROLIDINO)-2,1,3-BENZOXADIAZOLE; (R)-DBD-Py-NCS [=(R)-4-(N,N-dimethylaminosulfonyl)-7-(3-isothiocyanatopyrrolidino)-2,1,3-benzoxadiazole]; Dimethylaminosulfonylisothiocyanato; (R)-1-(7-(DIMETHYLAMINOSULFONYL)BD-4-YL) | ![]() | C13H15N5O3S2 | 详情 | 供应商 |
| 910656-27-8 | 4-(4-氟苯基)-7-[[[5-[(1S)-1-羟基-1-(三氟甲基)丙基]-1,3,4-恶二唑-2-基]氨基]甲基]-2H-1-苯并吡喃-2-酮; 4 | 4-(4-Fluorophenyl)-7-[[[5-[(1S)-1-hydroxy-1-(trifluoromethyl)propyl]-1,3,4-oxadiazol-2-yl]amino]meth | ![]() | C22H17F4N3O4 | 详情 | 供应商 |
| 937174-76-0 | 4-[2-(4-氨基-1,2,5-恶二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-? | 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4; 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol; GSK 690693; (R)-4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-(PIPERIDIN-3-YLMETHOXY)-1H-IMI | ![]() | C21H27N7O3 | 详情 | 供应商 |
| 254973-02-9 | AABD-SH (=4-乙酰氨基-7-巯基-2,1,3-苯并恶二唑][用于高效液相色谱标记] | AABD-SH (=4-Acetamido-7-mercapto-2,1,3-benzoxadiazole)[for HPLC Labeling] | 无 | 详情 | 供应商 | |
| 1151767-59-7 | 2-氨基-5-(3,5-二氟苄基)恶二唑; 2-氨基-5-(3,5-二氟苄基)恶二唑; 2-氨基-5-(3,5-二氟苄基)-1,3,4-恶二唑 | 2-AMino-5-(3,5-difluorobenzyl)oxadiazole, 97%; 2-AMino-5-(3,5-difluorobenzyl)oxadiazole, 97%; 2-AMino-5-(3,5-difluorobenzyl)-1,3,4-oxadiazole, 97% | 无 | 详情 | 供应商 | |
| 914471-09-3 | 4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒; 4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 | indoleaMine-2,3-dioxygenase inhibitor INCB024360; INCB 024360; INCB024360; INCB-024360; INCB-24360; indoleaMine-2,3-dioxygenase inhibitor INCB024360; INCB024360/INCB-024360; 4-Amino-N-(3-chloro-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide | 无 | C9H7ClFN5O2 | 详情 | 供应商 |